Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery when taken alongside chemotherapy. It has been recommended as an additional treatment for ...

Osimertinib, also known as Tagrisso and made by AstraZeneca, can help stop cancer from returning after surgery ...

In this video, Xiuning Le, MD, PhD, discusses how she approaches putting together a treatment plan for a patient with EGFR-mutated lung cancer.

In a significant move to alleviate the financial burden on patients, Finance Minister Nirmala Sitharaman announced in the ...

A DAILY pill that doubles survival time for lung cancer patients will be made routinely available on the NHS. Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from ...

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S. Kim, MD, MBA, discussed the FLAURA2 and MARIPOSA trials of newer regimens for ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

In February 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, ...

Dr Reddy’s Laboratories (pemetrexed) (confidentiality agreement not signed, not participating) Eli Lilly (pemetrexed) (confidentiality agreement not signed, not participating) Genus Pharmaceuticals ...

Union Finance Minister Nirmala Sitharaman on Saturday, February 1 announced 10,000 additional seats in medical colleges as ...